Stay updated with breaking news from Aezs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com began coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a research note released on Thursday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reiterated a buy rating and issued a $28.00 price objective on shares of Aeterna Zentaris in a report on Thursday, […]
StockNews.com initiated coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a research note released on Thursday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reaffirmed a buy rating and issued a $28.00 target price on shares of Aeterna Zentaris in a report on Thursday, […]
Aeterna Zentaris (NASDAQ:AEZS – Get Free Report) and Entrada Therapeutics (NASDAQ:TRDA – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, profitability, valuation, risk and earnings. Analyst Recommendations This is a summary of […]
StockNews.com started coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a report issued on Tuesday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reiterated a buy rating and issued a $28.00 target price on shares of Aeterna Zentaris in a research report on Thursday, August […]
Aeterna Zentaris Inc. (TSE:AEZS – Get Free Report)’s stock price was down 4.7% during mid-day trading on Thursday . The company traded as low as C$3.37 and last traded at C$3.45. Approximately 500 shares changed hands during mid-day trading, a decline of 61% from the average daily volume of 1,278 shares. The stock had previously […]